Smruthi Organics
Healthcare
540686 BSE
₹140.30
Close ·
- P/E
- 21.68
Close 4 Nov 2026 ₹140.30 +11.05 +8.55% 1Y
Start ₹129.25
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures at the close · EPS basis: Standalone · TTM
- ROCE
- 7.99%
- Debt to Equity
- 0.11
- EPS (TTM)
- ₹6.47
- Book Value
- ₹64.22
- Market Cap
- —
- P/E (TTM)
- 21.68
- P/B
- 2.18
- ROE
- 5.17%
- Dividend Yield
- 1.06%
- EBITDA
- ₹13.20 Cr
- 52W High
- ₹175.30
- 52W Low
- ₹95.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
62 Good
Data confidence 100/100
Category scores
- Quality
- 76
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 64
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 30
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 68
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 79
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company has been maintaining a healthy dividend payout of 48.7%
- Debtor days have improved from 93.5 to 69.1 days.
Weaknesses
2- The company has delivered a poor sales growth of -4.22% over past five years.
- Company has a low return on equity of 5.14% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 6 | 5 | 8 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Neutral
Bearish
2
Neutral
5
Bullish
2
Overall
Bullish
Bearish
6
Neutral
5
Bullish
8
Moving Averages
Strong Bullish
Bearish
4
Neutral
0
Bullish
6
Key readings
- RSI (14)
- 46.10
- Neutral
- MACD (12,26,9)
- −2.88
- Bullish
- SMA (50)
- 148.49
- Bearish
- SMA (200)
- 124.47
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +3.26% |
|---|---|
| 5Y | −4.14% |
| 3Y | −10.23% |
| 1Y | −19.05% |
| TTM | −4.54% |
Net profit
| 10Y | +11.61% |
|---|---|
| 5Y | −29.31% |
| 3Y | −9.14% |
| 1Y | −25.00% |
| TTM | +118.58% |
Operating cash flow
| 10Y | +4.62% |
|---|---|
| 5Y | −0.89% |
| 3Y | +22.39% |
| 1Y | +120.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −2.11 pp |
|---|---|
| 5Y | −10.27 pp |
| 3Y | +5.66 pp |
| 1Y | +3.23 pp |
| TTM | +6.45 pp |
Revenue by year
| Mar 2017 | ₹79.00 Cr |
|---|---|
| Mar 2018 | ₹97.00 Cr |
| Mar 2019 | ₹137 Cr |
| Mar 2020 | ₹131 Cr |
| Mar 2021 | ₹126 Cr |
| Mar 2022 | ₹133 Cr |
| Mar 2023 | ₹141 Cr |
| Mar 2024 | ₹128 Cr |
| Mar 2025 | ₹126 Cr |
| Mar 2026 | ₹102 Cr |
Net profit by year
| Mar 2017 | ₹2.00 Cr |
|---|---|
| Mar 2018 | −₹3.00 Cr |
| Mar 2019 | ₹7.00 Cr |
| Mar 2020 | ₹8.00 Cr |
| Mar 2021 | ₹17.00 Cr |
| Mar 2022 | ₹10.00 Cr |
| Mar 2023 | ₹4.00 Cr |
| Mar 2024 | ₹4.00 Cr |
| Mar 2025 | ₹4.00 Cr |
| Mar 2026 | ₹3.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34.91 | 29.59 | 23.48 | 39.66 | 27.27 | 29.39 | 31.25 | 38.09 | 18.85 | 31.6 | 22.29 | 29.05 | 29.3 |
| Expenses | 30.29 | 25.16 | 24.66 | 35.58 | 26.82 | 26.5 | 27.08 | 33.41 | 18.56 | 26.59 | 18.29 | 25.15 | 23.49 |
| Operating Profit | 4.62 | 4.43 | −1.18 | 4.08 | 0.45 | 2.89 | 4.17 | 4.68 | 0.29 | 5.01 | 4 | 3.9 | 5.81 |
| OPM % | 13.23% | 14.97% | −5.03% | 10.29% | 1.65% | 9.83% | 13.34% | 12.29% | 1.54% | 15.85% | 17.95% | 13.43% | 19.83% |
| Other Income | 0.01 | 0 | 0 | 0.06 | 0 | 0.01 | 0 | 0.08 | 0.04 | 0.01 | −0.44 | −0.07 | −0.04 |
| Interest | 0.33 | 0.39 | 0.32 | 0.37 | 0.41 | 0.44 | 0.51 | 0.52 | 0.46 | 0.66 | 0.25 | 0.31 | 0.31 |
| Depreciation | 1.24 | 1.38 | 1.45 | 1.59 | 1.29 | 1.33 | 1.37 | 1.5 | 1.41 | 1.51 | 1.67 | 1.75 | 1.6 |
| PBT | 3.06 | 2.66 | −2.95 | 2.18 | −1.25 | 1.13 | 2.29 | 2.74 | −1.54 | 2.85 | 1.64 | 1.77 | 3.86 |
| Tax % | 25.49% | 22.56% | −22.03% | 30.73% | −26.4% | 31.86% | 35.37% | 18.61% | −28.57% | 27.72% | 14.63% | 39.55% | 25.65% |
| Net Profit | 2.29 | 2.07 | −2.29 | 1.52 | −0.92 | 0.78 | 1.48 | 2.23 | −1.1 | 2.06 | 1.4 | 1.07 | 2.88 |
| EPS (₹) | 2 | 1.81 | −2 | 1.33 | −0.8 | 0.68 | 1.29 | 1.95 | −0.96 | 1.8 | 1.22 | 0.93 | 2.52 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 77 | 74 | 79 | 97 | 137 | 131 | 126 | 133 | 141 | 128 | 126 | 102 | 112 |
| Expenses | 72 | 63 | 69 | 94 | 121 | 116 | 98 | 115 | 131 | 116 | 114 | 89 | 94 |
| Operating Profit | 5 | 11 | 10 | 3 | 17 | 15 | 29 | 18 | 10 | 12 | 12 | 13 | 19 |
| OPM % | 6% | 14% | 13% | 3.4% | 12% | 12% | 23% | 14% | 7% | 9% | 10% | 13% | 17% |
| Other Income | 0 | 0 | 1 | 0 | 1 | 4 | 1 | 1 | 0 | 0 | 0 | 0 | −1 |
| Interest | 6 | 5 | 4 | 4 | 4 | 3 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 7 |
| PBT | −6 | 2 | 3 | −5 | 10 | 12 | 24 | 14 | 4 | 5 | 5 | 5 | 10 |
| Tax % | −33% | 55% | 39% | −31% | 30% | 30% | 29% | 25% | 8% | 28% | 27% | 27% | — |
| Net Profit | −4 | 1 | 2 | −3 | 7 | 8 | 17 | 10 | 4 | 4 | 4 | 3 | 7 |
| EPS (₹) | −3.34 | 0.63 | 1.39 | −2.82 | 6.02 | 7.41 | 14.95 | 9.07 | 3.61 | 3.14 | 3.11 | 3 | 6.47 |
| Div. Payout % | 0% | 0% | 0% | 0% | 11% | 14% | 20% | 33% | 55% | 48% | 48% | 50% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 26 | 27 | 28 | 25 | 33 | 39 | 49 | 56 | 57 | 58 | 60 | 62 |
| Borrowings | 45 | 37 | 33 | 31 | 28 | 16 | 10 | 3 | 6 | 12 | 17 | 8 |
| Other Liabilities | 34 | 35 | 20 | 25 | 37 | 30 | 21 | 18 | 32 | 37 | 23 | 22 |
| Total Liabilities | 109 | 103 | 85 | 85 | 101 | 88 | 92 | 88 | 106 | 118 | 112 | 104 |
| Fixed Assets | 35 | 32 | 30 | 30 | 30 | 32 | 31 | 33 | 37 | 40 | 45 | 47 |
| CWIP | 1 | 1 | 1 | 1 | 2 | 0 | 1 | 1 | 2 | 1 | 3 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 72 | 69 | 54 | 54 | 69 | 56 | 60 | 53 | 66 | 77 | 64 | 54 |
| Total Assets | 109 | 103 | 85 | 85 | 101 | 88 | 92 | 88 | 106 | 118 | 112 | 104 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 9 | 14 | 9 | 5 | 12 | 21 | 23 | 2 | 12 | 4 | 10 | 22 |
| Investing | −1 | 0 | 0 | −3 | −4 | −5 | −3 | 7 | −10 | −7 | −11 | −9 |
| Financing | −8 | −14 | −9 | −2 | −5 | −17 | −7 | −12 | −2 | 3 | 1 | −12 |
| Net Cash Flow | −1 | 0 | 0 | 0 | 2 | −1 | 13 | −3 | 0 | 0 | 0 | 1 |
| Free Cash Flow | 7 | 13 | 8 | 1 | 7 | 17 | 19 | −4 | 3 | −4 | −2 | 14 |
| CFO/OP | 184 | 128 | 93 | 159 | 71 | 160 | 101 | 33 | 136 | 46 | 100 | 182 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 95 | 97 | 95 | 97 | 68 | 62 | 78 | 96 | 117 | 94 | 69 |
| Inventory Days | 123 | 166 | 145 | 126 | 92 | 75 | 100 | 91 | 96 | 150 | 151 | 228 |
| Days Payable | 106 | 128 | 123 | 130 | 120 | 97 | 81 | 50 | 98 | 144 | 85 | 111 |
| Cash Conversion Cycle | 120 | 133 | 119 | 92 | 68 | 46 | 80 | 118 | 93 | 123 | 160 | 186 |
| Working Capital Days | 2 | 8 | 1 | 7 | 78 | 32 | 52 | 99 | 73 | 94 | 92 | 85 |
| ROCE % | 0% | 9% | 10% | −1% | 21% | 25% | 39% | 21% | 7% | 8% | 8% | 8% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Smruthi Organics insights
67 extracted metrics across FY10–FY27.
Documents
- 11 Mar 2026
- 22 Aug 2025
- 17 Mar 2025
- 6 Aug 2024
- 13 Feb 2024
- General announcements 6 Oct 2026
Frequently Asked Questions about Smruthi Organics
What does Smruthi Organics Ltd do?
Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients
Where is Smruthi Organics Ltd (SMRUTHIORG) listed?
Smruthi Organics Ltd trades under code 540686 on the BSE.
Which sector does Smruthi Organics Ltd belong to?
Smruthi Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Smruthi Organics Ltd?
Smruthi Organics Ltd trades at a PE ratio of 21.68 as of 4 Nov 2026, on earnings per share of ₹6.47, against a book value of ₹64.22 per share.
What is the 52-week high and low of Smruthi Organics Ltd?
Over the last 52 weeks Smruthi Organics Ltd has traded between ₹95 and ₹175.3 as of 4 Nov 2026.
Does Smruthi Organics Ltd pay dividends?
Smruthi Organics Ltd has a dividend yield of 1.06%.
What is the Return on Equity (ROE) of Smruthi Organics Ltd?
Smruthi Organics Ltd reported a return on equity of 5.17%. Its debt-to-equity ratio is 0.11.
Company Information
Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540686.md for Smruthi Organics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.